GlassScriptPhysician profile
Clifford T Baker
NPI 1235342775
$25,300.07
in general payments reported to CMS, 2019-2025
54 companies · $2,800 in 2025
The $2,800 reported for 2025 was more than what 84% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,301 · 2020: $2,836 · 2021: $3,683 · 2022: $6,143 · 2023: $2,790 · 2024: $4,747 · 2025: $2,800.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,522 · Travel and Lodging: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,522.29 |
| Travel and Lodging | $814.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,032.93 | 2019-2025 | Octrode, Proclaim, Eterna |
| Nevro Corp. | $4,216.32 | 2019-2023 | Senza |
| Boston Scientific Corporation | $3,098.06 | 2019-2025 | Intracept, Wavewriter Alpha Prime 16, General - Pain Management |
| Spinal Simplicity, LLC | $1,673.99 | 2024-2025 | Ha Minuteman G3-R, Liberty Si |
| Biotronik Nro, INC. | $1,263.47 | 2023-2025 | Prospera, Biotronik |
| Nalu Medical, INC. | $1,029.96 | 2021-2024 | Nalu Neurostimulation System |
| Medtronic, INC. | $693.44 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Kyphon Express II Kyphopak Tray |
| Medtronic USA, INC. | $589.35 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $551.50 | 2019-2025 | Xtampza, Belbuca |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $549.12 | 2019-2025 | Relistor |
| Saluda Medical Americas, INC. | $533.43 | 2023-2025 | Evoke, Evoke Scs |
| Abbvie INC. | $354.41 | 2021-2024 | Qulipta |
| Scilex Pharmaceuticals INC. | $336.42 | 2019-2024 | |
| Depuy Synthes Sales INC. | $324.80 | 2019-2024 | Orthovisc, Monovisc |
| Vertos Medical, INC. | $284.80 | 2019-2022 |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clifford Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.